Net Cash Provided by (Used in) Operating Activities |
-98.7K |
USD |
+68% |
Q3 2022 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
112K |
USD |
-61.3% |
Q3 2022 |
Q1 2023 |
Common Stock, Shares Authorized |
5B |
shares |
0% |
Q2 2023 |
FY 2023 |
Common Stock, Shares, Issued |
1.43B |
shares |
0% |
Q2 2023 |
FY 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2023 |
FY 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
7.78K |
USD |
|
Q3 2022 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
5.39K |
USD |
-28% |
Q2 2023 |
FY 2023 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
-100% |
Q3 2022 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
1.76M |
USD |
+6.98% |
Q2 2023 |
FY 2023 |
Depreciation |
4.37K |
USD |
-17.8% |
Q2 2023 |
FY 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-689K |
USD |
+66.3% |
Q2 2023 |
FY 2023 |
Property, Plant and Equipment, Gross |
63.9K |
USD |
-26.8% |
Q2 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.79M |
USD |
+13.2% |
Q2 2023 |
FY 2023 |
Deferred Federal Income Tax Expense (Benefit) |
0 |
USD |
|
Q1 2022 |
Q3 2022 |
Additional Paid in Capital |
1.06M |
USD |
+25.6% |
Q2 2023 |
FY 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
-100% |
Q2 2023 |
FY 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
1.79M |
USD |
+6.86% |
Q2 2023 |
FY 2023 |
Interest Expense |
450K |
USD |
-71.1% |
Q2 2023 |
FY 2023 |